DASH vs FOLD
DoorDash, Inc. Class A Common Stock (DASH) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the DASH and FOLD stock pages for the full models.
Not investment advice.